Tandem Capital Management Corp ADV Sells 4,200 Shares of Avantor, Inc. (NYSE:AVTR)

Tandem Capital Management Corp ADV decreased its stake in Avantor, Inc. (NYSE:AVTR) by 7.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 49,332 shares of the company’s stock after selling 4,200 shares during the period. Tandem Capital Management Corp ADV’s holdings in Avantor were worth $1,126,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in AVTR. Tokio Marine Asset Management Co. Ltd. raised its holdings in shares of Avantor by 3.8% during the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 18,725 shares of the company’s stock valued at $427,000 after buying an additional 685 shares in the last quarter. GAMMA Investing LLC purchased a new position in shares of Avantor during the fourth quarter worth approximately $47,000. California Public Employees Retirement System lifted its holdings in shares of Avantor by 0.3% in the 4th quarter. California Public Employees Retirement System now owns 1,025,220 shares of the company’s stock worth $23,406,000 after acquiring an additional 3,161 shares during the last quarter. Wedge Capital Management L L P NC boosted its stake in shares of Avantor by 15.3% in the 4th quarter. Wedge Capital Management L L P NC now owns 249,104 shares of the company’s stock valued at $5,687,000 after purchasing an additional 33,126 shares in the last quarter. Finally, Jennison Associates LLC grew its holdings in shares of Avantor by 31.4% during the 4th quarter. Jennison Associates LLC now owns 1,172,323 shares of the company’s stock valued at $26,764,000 after purchasing an additional 280,360 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Stock Down 1.3 %

AVTR stock traded down $0.33 during trading on Thursday, hitting $25.13. 6,252,582 shares of the stock traded hands, compared to its average volume of 5,709,651. The stock has a market cap of $17.05 billion, a price-to-earnings ratio of 52.35, a price-to-earnings-growth ratio of 2.61 and a beta of 1.37. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.61 and a quick ratio of 1.05. Avantor, Inc. has a 1 year low of $16.63 and a 1 year high of $26.16. The firm’s 50 day moving average is $25.08 and its two-hundred day moving average is $22.59.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, February 14th. The company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.22 by $0.03. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The business had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.70 billion. During the same period last year, the business posted $0.32 EPS. The company’s revenue was down 4.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Avantor, Inc. will post 1.01 EPS for the current year.

Insiders Place Their Bets

In related news, EVP James Bramwell sold 6,203 shares of Avantor stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total value of $151,911.47. Following the completion of the sale, the executive vice president now owns 101,143 shares of the company’s stock, valued at $2,476,992.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.50% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several analysts have weighed in on AVTR shares. Barclays boosted their price objective on Avantor from $27.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, April 10th. UBS Group increased their price target on shares of Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research report on Thursday, February 15th. Raymond James boosted their price objective on shares of Avantor from $22.50 to $26.00 and gave the company an “outperform” rating in a research report on Friday, January 26th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Thursday, April 18th. Finally, JPMorgan Chase & Co. raised their target price on Avantor from $26.00 to $29.00 and gave the stock an “overweight” rating in a research note on Thursday, February 15th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, Avantor presently has a consensus rating of “Moderate Buy” and a consensus target price of $26.71.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.